The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?

Affiliations

Comment

Gabriel Martins de Barros. Einstein (Sao Paulo). 2022.

. 2022 Nov 25:20:eCE0196.

doi: 10.31744/einstein_journal/2022CE0196. eCollection 2022.

No abstract available

Comment on

The global prevalence of latent tuberculosis: a systematic review and meta-analysis.
Cohen A, Mathiasen VD, Schön T, Wejse C. Cohen A, et al. Eur Respir J. 2019 Sep 12;54(3):1900655. doi: 10.1183/13993003.00655-2019. Print 2019 Sep. Eur Respir J. 2019. PMID: 31221810

1. Noori MA, Younes I, Latif A, Fichadiya H, Elkattawy S, Khandait H, et al. Reactivation of tuberculosis in the setting of COVID-19 infection. Cureus. 2022;14(3):e23417. - PMC - PubMed
1. Maia CM, Martelli DR, Silveira DM, Oliveira EA, Martelli H., Júnior Tuberculosis in Brazil: the impact of the COVID-19 pandemic. J Bras Pneumol. 2022;48(2):e20220082. - PMC - PubMed
1. Arsenault C, Gage A, Kim MK, Kapoor NR, Akweongo P, Amponsah F, et al. COVID-19 and resilience of healthcare systems in ten countries. Nature Med. 2022;28(6):1314–1324. - PMC - PubMed
1. Souza MD, Paz WS, Sales VB, Jesus GF, Tavares DD, Lima SV, et al. Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: is the WHO End TB Strategy at risk? Front pharmacol. 2022:2420–2420. - PMC - PubMed
1. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VØ, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002;185(3):401–404. - PubMed